These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 31981631)

  • 1. The benefits and mechanisms of exercise training for Parkinson's disease.
    Feng YS; Yang SD; Tan ZX; Wang MM; Xing Y; Dong F; Zhang F
    Life Sci; 2020 Mar; 245():117345. PubMed ID: 31981631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of mitochondrial dynamics by treadmill training to improve gait and mitochondrial deficiency in a rat model of Parkinson's disease.
    Chuang CS; Chang JC; Cheng FC; Liu KH; Su HL; Liu CS
    Life Sci; 2017 Dec; 191():236-244. PubMed ID: 28986095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise for Parkinson's disease.
    Mak MKY; Wong-Yu ISK
    Int Rev Neurobiol; 2019; 147():1-44. PubMed ID: 31607351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of endurance exercise training on the motor and non-motor features of Parkinson's disease: a review.
    Lamotte G; Rafferty MR; Prodoehl J; Kohrt WM; Comella CL; Simuni T; Corcos DM
    J Parkinsons Dis; 2015; 5(1):21-41. PubMed ID: 25374272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise and Parkinson's disease.
    Xu X; Fu Z; Le W
    Int Rev Neurobiol; 2019; 147():45-74. PubMed ID: 31607362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson disease and exercise.
    Earhart GM; Falvo MJ
    Compr Physiol; 2013 Apr; 3(2):833-48. PubMed ID: 23720332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New pharmacological options for treating advanced Parkinson's disease.
    Devos D; Moreau C; Dujardin K; Cabantchik I; Defebvre L; Bordet R
    Clin Ther; 2013 Oct; 35(10):1640-52. PubMed ID: 24011636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treadmill exercise intervention improves gait and postural control in alpha-synuclein mouse models without inducing cerebral autophagy.
    Minakaki G; Canneva F; Chevessier F; Bode F; Menges S; Timotius IK; Kalinichenko LS; Meixner H; Müller CP; Eskofier BM; Casadei N; Riess O; Schröder R; Winkler J; Xiang W; von Hörsten S; Klucken J
    Behav Brain Res; 2019 May; 363():199-215. PubMed ID: 30599154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.
    Sarkar S; Raymick J; Imam S
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing neurogenesis for the possible treatment of Parkinson's disease.
    Lamm O; Ganz J; Melamed E; Offen D
    J Comp Neurol; 2014 Aug; 522(12):2817-30. PubMed ID: 24723264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future.
    Fahn S
    Parkinsonism Relat Disord; 2018 Jan; 46 Suppl 1():S1-S5. PubMed ID: 28784297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aquatic exercise improves motor impairments in people with Parkinson's disease, with similar or greater benefits than land-based exercise: a systematic review.
    Cugusi L; Manca A; Bergamin M; Di Blasio A; Monticone M; Deriu F; Mercuro G
    J Physiother; 2019 Apr; 65(2):65-74. PubMed ID: 30904467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
    Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
    J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonmotor Symptoms and Natural History of Parkinson's Disease: Evidence From Cognitive Dysfunction and Role of Noninvasive Interventions.
    Biundo R; Fiorenzato E; Antonini A
    Int Rev Neurobiol; 2017; 133():389-415. PubMed ID: 28802926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence Supports PA Prescription for Parkinson's Disease: Motor Symptoms and Non-Motor Features: A Scoping Review.
    Cheng YC; Su CH
    Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32331349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gangliosides, α-Synuclein, and Parkinson's Disease.
    Ledeen RW; Wu G
    Prog Mol Biol Transl Sci; 2018; 156():435-454. PubMed ID: 29747823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of exercise and physical therapy in people with Parkinson disease.
    Mak MK; Wong-Yu IS; Shen X; Chung CL
    Nat Rev Neurol; 2017 Nov; 13(11):689-703. PubMed ID: 29027544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunction of serotonergic neurons in Parkinson's disease and dyskinesia.
    Vegas-Suarez S; Paredes-Rodriguez E; Aristieta A; Lafuente JV; Miguelez C; Ugedo L
    Int Rev Neurobiol; 2019; 146():259-279. PubMed ID: 31349930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease: Autoimmunity and neuroinflammation.
    De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
    Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
    Dafsari HS; Silverdale M; Strack M; Rizos A; Ashkan K; Mahlstedt P; Sachse L; Steffen J; Dembek TA; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Mov Disord; 2018 Mar; 33(3):421-430. PubMed ID: 29465787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.